Artelo Biosciences (ARTL) vs Endovia Health Sciences (EDVA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Artelo Biosciences is the larger company by market cap ($1.8 million vs $1.8 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ARTL | EDVA |
|---|---|---|
| Share price | $3.37 | $0.1599 |
| Market cap | $1.85M | $1.77M |
| 1-day change | -1.17% | -3.09% |
| EPS (TTM) | $-136.26 | $-21.94 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $179.19 | $13.40 |
| 52-week low | $3.33 | $0.15 |
| Distance from 52-week high | -98.12% | -98.81% |
| Average volume | 480.72K | 4.50M |
| Shares outstanding | 547.77K | 11.08M |
| Employees | 7 | 1 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Artelo Biosciences
ARTL stock →Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. The company's product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of cancer-related anorexia; and ART12.11, a cocrystal composition of cannabidiol and tetramethylpyrazine for the treatment anxiety, depression, post-traumatic stress disorder PTSD, epilepsy and insomnia, and other potential indications.
Healthcare · Biotechnology · 7 employees
About Endovia Health Sciences
EDVA stock →Endovia Health Sciences, Inc. develops a diversified cannabinoid health sciences platform that translates science into regulated therapies and trusted health and wellness products for people and animals in Ireland, United Kingdom, Australia, and Latin America.
Healthcare · Biotechnology · 1 employees
ARTL vs EDVA FAQ
Which is bigger, Artelo Biosciences or Endovia Health Sciences?
Artelo Biosciences (ARTL) is larger, with a market capitalization of $1.85M compared with $1.77M for Endovia Health Sciences (EDVA).
Are Artelo Biosciences and Endovia Health Sciences in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.